| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000023047 |
| Receipt No. | R000026401 |
| Official scientific title of the study | Evaluation of myocardial triglyceride content assessed on 1H-Magnetic Resonance Spectroscopy in subjects with cardiovascular risk |
| Date of disclosure of the study information | 2016/07/11 |
| Last modified on | 2018/01/17 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation of myocardial triglyceride content assessed on 1H-Magnetic Resonance Spectroscopy in subjects with cardiovascular risk | |
| Title of the study (Brief title) | Evaluation of myocardial triglyceride content assessed on 1H-Magnetic Resonance Spectroscopy in subjects with cardiovascular risk | |
| Region |
|
|
| Condition | ||
| Condition | Hypertension, Dyslipidemia, Diabetes Mellitus, Obesity, Sleep apnea syndrome, Coronary artery disease, Chronic heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of myocardial triglyceride content assessed on 1H-Magnetic Resonance Spectroscopy in subjects with cardiovascular risk and cardiac disease |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of the association between myocardial triglyceride content and clinical parameters in subjects with cardiovascular risk and cardiac disease |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients provided written informed consent 2.Patients with presence of clinical or subclinical cardiovascular disease or at least one cardiovascular disease risk factors 1)Serum levels of triglyceride >= 150mg/dl or HDL-C < 40mg/dl 2)Systolic blood pressure >= 130mmHg or diastolic blood pressure >= 85mmHg 3)Plasma levels of fasting blood suger >= 110mg/dl 4)Body mass index >= 25kg/square meter 5)Apnea-hypopnea index >= 5 3.Patients with history of caridac disease 4.Patients with history of coronary artery disease |
|||
| Key exclusion criteria | 1)Patients with contraindication of MRI 2)Patients who judged as ineligible by clinical staffs |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunori Shimada |
| Organization | Juntendo University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 2-1-1 Hongo Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3813-3111 |
| shimakaz@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Makoto Hiki |
| Organization | Juntendo University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 2-1-1 Hongo Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3813-3111 |
| Homepage URL | |
| m-hiki@juntendo.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | ongoing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026401 |